Overview of long term care of breast cancer survivors.
Identifieur interne : 004C77 ( Main/Exploration ); précédent : 004C76; suivant : 004C78Overview of long term care of breast cancer survivors.
Auteurs : Meagan E. Brennan [Australie] ; Nehmat HoussamiSource :
- Maturitas [ 1873-4111 ] ; 2011.
Descripteurs français
- KwdFr :
- Antinéoplasiques hormonaux (effets indésirables), Antinéoplasiques hormonaux (usage thérapeutique), Bouffées de chaleur (), Bouffées de chaleur (étiologie), Femelle, Humains, Maladies du vagin (), Maladies du vagin (étiologie), Ménopause précoce, Santé holistique, Soins de longue durée, Survivants, Tamoxifène (effets indésirables), Tamoxifène (usage thérapeutique), Tumeurs de l'endomètre (étiologie), Tumeurs du sein (diagnostic), Tumeurs du sein (traitement médicamenteux).
- MESH :
- diagnostic : Tumeurs du sein.
- effets indésirables : Antinéoplasiques hormonaux, Tamoxifène.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques hormonaux, Tamoxifène.
- étiologie : Bouffées de chaleur, Maladies du vagin, Tumeurs de l'endomètre.
- Bouffées de chaleur, Femelle, Humains, Maladies du vagin, Ménopause précoce, Santé holistique, Soins de longue durée, Survivants.
English descriptors
- KwdEn :
- Antineoplastic Agents, Hormonal (adverse effects), Antineoplastic Agents, Hormonal (therapeutic use), Breast Neoplasms (diagnosis), Breast Neoplasms (drug therapy), Endometrial Neoplasms (etiology), Female, Holistic Health, Hot Flashes (etiology), Hot Flashes (therapy), Humans, Long-Term Care, Menopause, Premature, Survivors, Tamoxifen (adverse effects), Tamoxifen (therapeutic use), Vaginal Diseases (etiology), Vaginal Diseases (therapy).
- MESH :
- chemical , adverse effects : Antineoplastic Agents, Hormonal, Tamoxifen.
- chemical , therapeutic use : Antineoplastic Agents, Hormonal, Tamoxifen.
- diagnosis : Breast Neoplasms.
- drug therapy : Breast Neoplasms.
- etiology : Endometrial Neoplasms, Hot Flashes, Vaginal Diseases.
- therapy : Hot Flashes, Vaginal Diseases.
- Female, Holistic Health, Humans, Long-Term Care, Menopause, Premature, Survivors.
Abstract
Breast cancer, the most common cancer in women in developed countries, has a generally excellent prognosis, therefore long-term survivors living with the consequences of breast cancer ('survivors') and its treatment are an increasing group in clinical practice. This review discusses the complex issues relevant to survivorship care, including current recommendations for ongoing adjuvant hormonal therapy (tamoxifen and aromatase inhibitors), and the management of side effects of cancer treatment (such as menopause, arthralgia, and lymphoedema). Annual mammography screening is advised for detection of second breast cancers, and symptom-directed assessment is warranted where there is suspicion of distant recurrence or (in women using tamoxifen) of endometrial cancer. Management of menopausal symptoms, including treatment-induced premature menopause, is a key issue for many survivors, and can be challenging to manage as conventional hormone replacement therapy is contraindicated in most of these women. Specific therapeutic options for hot flushes and vaginal symptoms are discussed. The review also emphasises the need for survivorship care to include optimisation of general health, including psychosocial and sexual health, bone health and the evaluation of lifestyle-related risk factors and genetic factors. The review provides guidance on the management of many of these issues, and highlights areas requiring further evidence and research.
DOI: 10.1016/j.maturitas.2011.03.010
PubMed: 21489727
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002670
- to stream PubMed, to step Curation: 002670
- to stream PubMed, to step Checkpoint: 002670
- to stream Ncbi, to step Merge: 004275
- to stream Ncbi, to step Curation: 004275
- to stream Ncbi, to step Checkpoint: 004275
- to stream Main, to step Merge: 004D11
- to stream Main, to step Curation: 004C77
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Overview of long term care of breast cancer survivors.</title>
<author><name sortKey="Brennan, Meagan E" sort="Brennan, Meagan E" uniqKey="Brennan M" first="Meagan E" last="Brennan">Meagan E. Brennan</name>
<affiliation wicri:level="1"><nlm:affiliation>Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Camperdown, Sydney, NSW, Australia. meagan.brennan@sydney.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Camperdown, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Houssami, Nehmat" sort="Houssami, Nehmat" uniqKey="Houssami N" first="Nehmat" last="Houssami">Nehmat Houssami</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21489727</idno>
<idno type="pmid">21489727</idno>
<idno type="doi">10.1016/j.maturitas.2011.03.010</idno>
<idno type="wicri:Area/PubMed/Corpus">002670</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002670</idno>
<idno type="wicri:Area/PubMed/Curation">002670</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002670</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002670</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002670</idno>
<idno type="wicri:Area/Ncbi/Merge">004275</idno>
<idno type="wicri:Area/Ncbi/Curation">004275</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004275</idno>
<idno type="wicri:Area/Main/Merge">004D11</idno>
<idno type="wicri:Area/Main/Curation">004C77</idno>
<idno type="wicri:Area/Main/Exploration">004C77</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Overview of long term care of breast cancer survivors.</title>
<author><name sortKey="Brennan, Meagan E" sort="Brennan, Meagan E" uniqKey="Brennan M" first="Meagan E" last="Brennan">Meagan E. Brennan</name>
<affiliation wicri:level="1"><nlm:affiliation>Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Camperdown, Sydney, NSW, Australia. meagan.brennan@sydney.edu.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Camperdown, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Houssami, Nehmat" sort="Houssami, Nehmat" uniqKey="Houssami N" first="Nehmat" last="Houssami">Nehmat Houssami</name>
</author>
</analytic>
<series><title level="j">Maturitas</title>
<idno type="eISSN">1873-4111</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents, Hormonal (adverse effects)</term>
<term>Antineoplastic Agents, Hormonal (therapeutic use)</term>
<term>Breast Neoplasms (diagnosis)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Endometrial Neoplasms (etiology)</term>
<term>Female</term>
<term>Holistic Health</term>
<term>Hot Flashes (etiology)</term>
<term>Hot Flashes (therapy)</term>
<term>Humans</term>
<term>Long-Term Care</term>
<term>Menopause, Premature</term>
<term>Survivors</term>
<term>Tamoxifen (adverse effects)</term>
<term>Tamoxifen (therapeutic use)</term>
<term>Vaginal Diseases (etiology)</term>
<term>Vaginal Diseases (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques hormonaux (effets indésirables)</term>
<term>Antinéoplasiques hormonaux (usage thérapeutique)</term>
<term>Bouffées de chaleur ()</term>
<term>Bouffées de chaleur (étiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladies du vagin ()</term>
<term>Maladies du vagin (étiologie)</term>
<term>Ménopause précoce</term>
<term>Santé holistique</term>
<term>Soins de longue durée</term>
<term>Survivants</term>
<term>Tamoxifène (effets indésirables)</term>
<term>Tamoxifène (usage thérapeutique)</term>
<term>Tumeurs de l'endomètre (étiologie)</term>
<term>Tumeurs du sein (diagnostic)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term>
<term>Tamoxifen</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term>
<term>Tamoxifen</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques hormonaux</term>
<term>Tamoxifène</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Endometrial Neoplasms</term>
<term>Hot Flashes</term>
<term>Vaginal Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hot Flashes</term>
<term>Vaginal Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques hormonaux</term>
<term>Tamoxifène</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Bouffées de chaleur</term>
<term>Maladies du vagin</term>
<term>Tumeurs de l'endomètre</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Holistic Health</term>
<term>Humans</term>
<term>Long-Term Care</term>
<term>Menopause, Premature</term>
<term>Survivors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Bouffées de chaleur</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladies du vagin</term>
<term>Ménopause précoce</term>
<term>Santé holistique</term>
<term>Soins de longue durée</term>
<term>Survivants</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Breast cancer, the most common cancer in women in developed countries, has a generally excellent prognosis, therefore long-term survivors living with the consequences of breast cancer ('survivors') and its treatment are an increasing group in clinical practice. This review discusses the complex issues relevant to survivorship care, including current recommendations for ongoing adjuvant hormonal therapy (tamoxifen and aromatase inhibitors), and the management of side effects of cancer treatment (such as menopause, arthralgia, and lymphoedema). Annual mammography screening is advised for detection of second breast cancers, and symptom-directed assessment is warranted where there is suspicion of distant recurrence or (in women using tamoxifen) of endometrial cancer. Management of menopausal symptoms, including treatment-induced premature menopause, is a key issue for many survivors, and can be challenging to manage as conventional hormone replacement therapy is contraindicated in most of these women. Specific therapeutic options for hot flushes and vaginal symptoms are discussed. The review also emphasises the need for survivorship care to include optimisation of general health, including psychosocial and sexual health, bone health and the evaluation of lifestyle-related risk factors and genetic factors. The review provides guidance on the management of many of these issues, and highlights areas requiring further evidence and research.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Houssami, Nehmat" sort="Houssami, Nehmat" uniqKey="Houssami N" first="Nehmat" last="Houssami">Nehmat Houssami</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Brennan, Meagan E" sort="Brennan, Meagan E" uniqKey="Brennan M" first="Meagan E" last="Brennan">Meagan E. Brennan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004C77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:21489727 |texte= Overview of long term care of breast cancer survivors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21489727" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |